Alev Yilmaz1, Zeynep Yuruk Yildirim2, Sevinc Emre1, Asuman Gedikbasi3, Tarik Yildirim4, Ahmet Dirican5, Evren Onay Ucar6. 1. Istanbul Faculty of Medicine, Pediatric Nephrology Department, Istanbul University, 34390, Capa, Istanbul, Turkey. 2. Istanbul Faculty of Medicine, Pediatric Nephrology Department, Istanbul University, 34390, Capa, Istanbul, Turkey. znyuruk@gmail.com. 3. Biochemistry Department, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey. 4. Pediatrics Department, Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey. 5. Biostatistics Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. 6. Department of Molecular Biology & Genetics, Faculty of Science, Istanbul University, Istanbul, Turkey.
Abstract
BACKGROUND: Heat shock proteins (HSPs) are a multi-family group of proteins which are upregulated by the cell in response to exposure to hazardous (stress) factors, including infectious agents, to prevent changes in protein structure. The aim of our study was to assess whether urine levels of the 70-kDa family of HSPs (HSP70s) increase in children with urinary tract infection (UTI) and to determine the optimal urine (u) HSP70 cut-off level to predict UTI in children. METHODS: Forty patients with symptomatic UTI (UTI group), 30 healthy children (control group), 21 asymptomatic patients with proven bacterial contamination in their urine culture (contamination group) and 30 patients with fever caused by other infections (non-UTI infection group) were enrolled in the study. Random urine samples were obtained for measurement of HSP70 and creatinine (Cr) from all groups. Urine was collected prior to the treatment of UTI at the time of presentation and after treatment. Urine HSP70 levels were measured by enzyme-linked immunosorbent analysis. A dimercaptosuccinic acid (DMSA) scan was performed at 5-7 days after presentation in UTI group to distinguish patients with acute pyelonephritis from those with cystitis; based on this scan, no patients had acute pyelonephritis. Patients were classified with pyelonephritis in the presence of all of the following signs: axillary fever of ≥39 °C, leukocytosis and positivity for C-reactive protein. RESULTS: The mean urine HSP70:Cr ratio (uHSP70/Cr) prior to treatment was significantly higher in the UTI group (449.86 ± 194.33 pg/mg) than in the control, contamination and non-UTI infection groups (39.93 ± 47.61, 32.43 ± 9.09 and 45.14 ± 19.76, respectively; p = 0.0001). Using a cut-off of 158 pg/mg uHSP70/Cr for the prediction of UTI, the sensitivity and specificity of the assay were 100 and 100 %, respectively (area under the time-concentration curve = 1). The uHSP70/Cr was highest in the patients with clinical pyelonephritis (p = 0.001). Mean uHSP70/Cr after treatment decreased to 60.68 ± 51.11 pg/mg in UTI group (p = 0 .0001). CONCLUSIONS: Our findings suggest that elevated uHSP70/Cr may be a useful biomarker for the prediction of UTI in children, with a high sensitivity and specificity, and that they may help to distinguish UTI from other infections as well as bacterial contamination of the urine.
BACKGROUND: Heat shock proteins (HSPs) are a multi-family group of proteins which are upregulated by the cell in response to exposure to hazardous (stress) factors, including infectious agents, to prevent changes in protein structure. The aim of our study was to assess whether urine levels of the 70-kDa family of HSPs (HSP70s) increase in children with urinary tract infection (UTI) and to determine the optimal urine (u) HSP70 cut-off level to predict UTI in children. METHODS: Forty patients with symptomatic UTI (UTI group), 30 healthy children (control group), 21 asymptomatic patients with proven bacterial contamination in their urine culture (contamination group) and 30 patients with fever caused by other infections (non-UTI infection group) were enrolled in the study. Random urine samples were obtained for measurement of HSP70 and creatinine (Cr) from all groups. Urine was collected prior to the treatment of UTI at the time of presentation and after treatment. Urine HSP70 levels were measured by enzyme-linked immunosorbent analysis. A dimercaptosuccinic acid (DMSA) scan was performed at 5-7 days after presentation in UTI group to distinguish patients with acute pyelonephritis from those with cystitis; based on this scan, no patients had acute pyelonephritis. Patients were classified with pyelonephritis in the presence of all of the following signs: axillary fever of ≥39 °C, leukocytosis and positivity for C-reactive protein. RESULTS: The mean urine HSP70:Cr ratio (uHSP70/Cr) prior to treatment was significantly higher in the UTI group (449.86 ± 194.33 pg/mg) than in the control, contamination and non-UTI infection groups (39.93 ± 47.61, 32.43 ± 9.09 and 45.14 ± 19.76, respectively; p = 0.0001). Using a cut-off of 158 pg/mg uHSP70/Cr for the prediction of UTI, the sensitivity and specificity of the assay were 100 and 100 %, respectively (area under the time-concentration curve = 1). The uHSP70/Cr was highest in the patients with clinical pyelonephritis (p = 0.001). Mean uHSP70/Cr after treatment decreased to 60.68 ± 51.11 pg/mg in UTI group (p = 0 .0001). CONCLUSIONS: Our findings suggest that elevated uHSP70/Cr may be a useful biomarker for the prediction of UTI in children, with a high sensitivity and specificity, and that they may help to distinguish UTI from other infections as well as bacterial contamination of the urine.
Authors: Gabrielle J Williams; Petra Macaskill; Siew F Chan; Robin M Turner; Elisabeth Hodson; Jonathan C Craig Journal: Lancet Infect Dis Date: 2010-04 Impact factor: 25.071
Authors: E L Davies; M M F V G Bacelar; M J Marshall; E Johnson; T D Wardle; S M Andrew; J H H Williams Journal: Clin Exp Immunol Date: 2006-07 Impact factor: 4.330
Authors: Diana Lebherz-Eichinger; Hendrik J Ankersmit; Stefan Hacker; Hubert Hetz; Oliver Kimberger; Elisabeth M Schmidt; Thomas Reiter; Walter H Hörl; Martin Haas; Claus G Krenn; Georg A Roth Journal: Clin Chim Acta Date: 2011-10-18 Impact factor: 3.786
Authors: Eva Karoly; Andrea Fekete; Nora F Banki; Beata Szebeni; Adam Vannay; Attila J Szabo; Tivadar Tulassay; Georg S Reusz Journal: Pediatr Res Date: 2007-03 Impact factor: 3.756
Authors: Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood Journal: J Biol Chem Date: 2002-02-08 Impact factor: 5.157
Authors: Julius F Varano Della Vergiliana; Sally M Lansley; Jose M Porcel; Silvia Bielsa; Jeremy S Brown; Jenette Creaney; Suzanna E L Temple; Grant W Waterer; Y C Gary Lee Journal: PLoS One Date: 2013-05-21 Impact factor: 3.240